Keyphrases
Asthma
67%
Oscillometry
50%
Severe Asthma
43%
Airway Hyperresponsiveness
34%
Small Airway Dysfunction
34%
Benralizumab
34%
Asthma Control
32%
Spirometry
29%
Biologic Therapy
28%
Forced Expiratory Volume in 1 Second (FEV1)
28%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
28%
Dupilumab
27%
Asthma Patients
27%
Persistent Asthma
25%
Small Airways
23%
Moderate-to-severe Asthma
23%
Inhaled Corticosteroids
22%
Asthma Exacerbation
21%
Airway
21%
Impulse Oscillometry
20%
Mannitol
19%
Mepolizumab
19%
Severe Eosinophilic Asthma
18%
Type 2 Biomarker
17%
Omalizumab
16%
Nasal Polyps
16%
Asthma Phenotypes
15%
Lung Function
14%
Fractional Exhaled Nitric Oxide (FeNO)
14%
Reliever Therapy
14%
Budesonide
13%
Allergic Asthma
13%
Anti-inflammatory Reliever
12%
Bronchodilator Response
12%
Bronchial Wall Thickening
12%
Asthma Control Questionnaire
12%
Disease Control
12%
Eosinophils
11%
Type 2 Inflammation
11%
Peripheral Blood Eosinophils
11%
Reactance
10%
Nasal Polyp Score
10%
Mucus Plug
10%
Blood Eosinophils
10%
Tezepelumab
10%
Comorbidity
10%
FEF25-75
9%
Sino-Nasal Outcome Test
9%
Systemic Effects
9%
Polypectomy
9%
Medicine and Dentistry
Asthma
100%
Oscillometry
60%
Nasal Polyp
39%
Severe Asthma
38%
Biological Product
35%
Chronic Rhinosinusitis
31%
Benralizumab
31%
Eosinophilic
21%
Spirometry
19%
Eosinophil
16%
Respiratory Tract Allergy
15%
Biological Therapy
14%
Dupilumab
14%
Diseases
14%
Mepolizumab
12%
Lung
12%
Immunoglobulin E
12%
Endotype
11%
Omalizumab
10%
Cytokine
9%
Tezepelumab
9%
Asthma Exacerbation
8%
Polypectomy
7%
Mannitol
7%
Asthma Control Questionnaire
7%
Allergic Asthma
7%
Prospective Cohort Study
6%
B Cell
6%
Bronchodilating Agent
6%
Lung Mechanics
6%
Lymphoproliferative Disease
6%
Retrospective Study
6%
Functional Endoscopic Sinus Surgery
6%
Alarmin
6%
Asthma in Adults
6%
Asthma in Children
6%
Airway Physiology
6%
Methacholine
6%
Respiratory System
6%
Allergen
6%
Quality of Life
6%
Recurrent Disease
5%
Nitric Oxide
5%
Body Mass Index
5%
Breathing
5%